Innoviva, Inc. - Significant Ownership

Signature - Title
/s/ Pavel Raifeld - Pavel Raifeld, Chief Executive Officer
Location
Burlingame, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Innoviva, Inc..

Significant Ownership of Innoviva, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMP Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value 83.3% $76M -$11.9M 55.5M -13.6% Innoviva, Inc. Aug 11, 2025

Schedules 13D/G Reported by Innoviva, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.